StockNews.com Initiates Coverage on Aethlon Medical (NASDAQ:AEMD)

StockNews.com assumed coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a report released on Friday morning. The firm issued a sell rating on the medical equipment provider’s stock.

Separately, HC Wainwright reaffirmed a “buy” rating and set a $7.00 price objective on shares of Aethlon Medical in a report on Friday, November 15th.

Aethlon Medical Stock Performance

NASDAQ:AEMD opened at $0.80 on Friday. The stock has a 50-day moving average price of $0.46 and a 200 day moving average price of $0.43. The stock has a market capitalization of $11.17 million, a P/E ratio of -0.28 and a beta of 1.61. Aethlon Medical has a 12-month low of $0.24 and a 12-month high of $2.23.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.